Molecular Imaging: Page 29

Canada grapples with shortage of SPECT agent

By Will Morton

Due to production delays, Canada is facing a shortage of dypyridamole -- an agent used in SPECT myocardial perfusion imaging (MPI) to diagnose coronary artery disease.

July 17, 2023

How should patients manage Lu-PSMA-617 waste disposal?

By Will Morton

A medical physicist in Iowa has crunched the numbers and determined the safest approach for prostate cancer patients receiving Lu-PSMA-617 (Pluvicto) to dispose of their radioactive urine, according to a recent communication in the Journal of Nuclear Medicine.

July 16, 2023

Is PSMA PET/CT cost-effective for primary staging?

By Will Morton

PET/CT scans in patients with prostate cancer may increase costs in Europe and the U.S., yet these costs may be reasonably low compared to the potential expenses of an inaccurate diagnosis, according to a recent study.

July 13, 2023

Male orgasms stimulate the brain's opioid system

By Will Morton

PET brain imaging has revealed a potential treatment target for men with orgasm disorders, with scans revealing that orgasms activate the brain's opioid system, according to a group in Finland.

July 13, 2023

Pluvicto patient response criteria validated

By Will Morton

Doctors now have a reliable approach for determining whether prostate cancer patients are responding to prostate cancer treatment with Pluvicto, according to research published July 11 in Radiology.

July 11, 2023

SNMMI calls for clarity over Leqembi PET scans

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imagine (SNMMI) has called for clarity over whether amyloid PET scans will be covered for potential candidates for the new Alzheimer's disease drug Leqembi (lecanemab).

July 10, 2023

FDA grants full approval to Alzheimer's disease drug Leqembi

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has granted full approval for Eisai and Biogen's Alzheimer's disease drug Leqembi (lecanemab).

July 6, 2023

RaySearch touts selection by Taiwanese hospital

By AuntMinnie.com staff writers

RaySearch Laboratories is highlighting that the proton therapy machine vendor Sumitomo recently placed an order for the RayStation treatment planning system, which will be installed at the Taichung Veterans General Hospital in Taiwan.

July 6, 2023

F-18 flurpiridaz PET effective in obese patients with CAD

By Will Morton

A clinical trial of F-18 flurpiridaz PET for detecting coronary artery disease (CAD) met a key outcome by showing effectiveness in obese patients, according to a talk at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

July 4, 2023

Genomic data, tau PET can identify Alzheimer's subtype

By Erik L. Ridley

The four Alzheimer's disease subtypes can be identified by a computational method that incorporates genomic and tau PET imaging data, according to a study presented at the annual Society of Nuclear Medicine and Molecular Imaging meeting.

July 2, 2023

AI developed for staging patients with prostate cancer

By Will Morton

An AI model based on prostate-specific membrane antigen-PET/CT imaging performs well in staging prostate cancer patients for surgery, according to a talk at the Society for Nuclear Medicine and Molecular Imaging meeting in Chicago.

July 2, 2023

Canada to invest $26.6M for medical isotope development

By AuntMinnie.com staff writers

The Canadian government will invest $26.6 million U.S. toward producing and distributing medical isotopes and radiopharmaceuticals.

June 29, 2023

Previous Page

Page 29 of 610

Next Page